Andere Kunden interessierten sich auch für
![A Healthy Society: How a Focus on Health Can Revive Canadian Democracy]( "A Healthy Society: How a Focus on Health Can Revive Canadian Democracy")
A Healthy Society: How a Focus on Health Can Revive Canadian Democracy24,99 €![Evolution of Department of Defense Disability Evaluation and Management of Posttraumatic Stress Disorder and Traumatic Brain Injury: Overview of Polic]( "Evolution of Department of Defense Disability Evaluation and Management of Posttraumatic Stress Disorder and Traumatic Brain Injury: Overview of Polic")
Evolution of Department of Defense Disability Evaluation and Management of Posttraumatic Stress Disorder and Traumatic Brain Injury: Overview of Polic22,99 €![Health, Well-Being and Older People]( "Health, Well-Being and Older People")
Health, Well-Being and Older People51,99 €![Redirecting Innovation in U.S. Health Care]( "Redirecting Innovation in U.S. Health Care")
Redirecting Innovation in U.S. Health Care36,99 €![Assessing Patient Safety Practices and Outcomes in the U.S. Health Care System]( "Assessing Patient Safety Practices and Outcomes in the U.S. Health Care System")
Assessing Patient Safety Practices and Outcomes in the U.S. Health Care System35,99 €![Chinese Older People: A Need for Social Inclusion in Two Communities]( "Chinese Older People: A Need for Social Inclusion in Two Communities")
Chinese Older People: A Need for Social Inclusion in Two Communities38,99 €![Stronger Links: A Guide to Good Practice for Children's Family-Based Short-Term Care Services]( "Stronger Links: A Guide to Good Practice for Children's Family-Based Short-Term Care Services")
Stronger Links: A Guide to Good Practice for Children's Family-Based Short-Term Care Services40,99 €
Jena and Philipson argue that further use of cost-effectiveness thresholds to curb health care spending may do more harm than good. Governments should adopt a more inclusive way of costeffectiveness, one that reflects not only the short term costs to patients but also the long-term effect on medical innovation. Policy makers should provide sufficient incentives for companies to develop new health technologies - or risk a dangerous shortage of life-saving drugs in the future.